Donald E. Cutlip

Active 1998–2025

Also published as
Donald E Cutlip
122
Papers
51,330
Citations
88
h-index
119
i10-index

Citations

Citations per year for Donald E. Cutlip1996: 5 citations1998: 6 citations1999: 19 citations2000: 31 citations2001: 39 citations2002: 38 citations2003: 57 citations2004: 83 citations2005: 159 citations2006: 140 citations2007: 224 citations2008: 244 citations2009: 245 citations2010: 253 citations2011: 410 citations2012: 414 citations2013: 367 citations2014: 316 citations2015: 388 citations2016: 327 citations2017: 294 citations2018: 277 citations2019: 1,096 citations2020: 1,147 citations2021: 939 citations2022: 670 citations2023: 529 citations2024: 932 citations2025: 388 citations2026: 21 citations1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,278 citing papers, 19.9% of this breakdownGermany: 1,201 citing papers, 7.3% of this breakdownItaly: 1,195 citing papers, 7.2% of this breakdownUnited Kingdom: 1,162 citing papers, 7% of this breakdownNetherlands: 876 citing papers, 5.3% of this breakdownFrance: 816 citing papers, 4.9% of this breakdownCanada: 767 citing papers, 4.6% of this breakdownSwitzerland: 616 citing papers, 3.7% of this breakdownJapan: 592 citing papers, 3.6% of this breakdownChina: 539 citing papers, 3.3% of this breakdownSpain: 539 citing papers, 3.3% of this breakdownBelgium: 423 citing papers, 2.6% of this breakdown
0%19.9%Other 27.3%

Fields

  • Medicine94.7%
  • Engineering1.8%
  • Biochemistry, Genetics and Molecular Biology1.2%
  • Materials Science0.4%
  • Economics, Econometrics and Finance0.3%
  • Health Professions0.3%
  • Other1.3%

Topics

  • Coronary Interventions and Diagnostics13%
  • Acute Myocardial Infarction Research7.8%
  • Antiplatelet Therapy and Cardiovascular Diseases7.2%
  • Cardiac Imaging and Diagnostics6.3%
  • Cardiac Valve Diseases and Treatments5.9%
  • Cerebrovascular and Carotid Artery Diseases4.5%
  • Other55.3%

Coauthors

All papers

Open in search
  1. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 4,423

  2. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2018 cited by 933

  3. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple - Circulation 2018 cited by 713

  4. Clinical End Points in Coronary Stent Trials

    Authors: , , , , , , , , , , , , , , - Circulation 2007 cited by 5,420

  5. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - Circulation 2019 cited by 796

  6. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - European Heart Journal 2019 cited by 572

  7. Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,988

  8. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 1,898

  9. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer and 4 more - The Lancet 2022 cited by 235

  10. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 174

  11. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 cited by 322

  12. Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2012 cited by 1,662

  13. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials

    Authors: , , , , , , , , , , , , , , , - Circulation 2014 cited by 704

  14. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William J. Nicholson, Yoshinobu Onuma, Georgios Sianos, Satoru Sumitsuji, Etsuo Tsuchikane, Renu Virmani, Simon Walsh, Gerald S. Werner, Masahisa Yamane, Gregg W. Stone, Stéphane Rinfret, Gregg W. Stone - Circulation 2021 cited by 290

  15. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , - JAMA 2016 cited by 911

  16. Standardized End Point Definitions for Coronary Intervention Trials

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 311

  17. Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 367

  18. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

    Authors: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 1,007

  19. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott D. Solomon, Jean-Noël Trochu, Dirk J. Van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah, on behalf of the REDUCE LAP-HF-II Investigators - Circulation 2022 cited by 120

  20. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernest Spitzer - Circulation 2022 cited by 74

  21. Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2004 cited by 2,853

  22. Supervised Exercise Versus Primary Stenting for Claudication Resulting From Aortoiliac Peripheral Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 496

  23. Obesity in Heart Failure with Preserved Ejection Fraction: Insights from the REDUCE LAP-HF II Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2023 cited by 24

  24. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2011 cited by 734